Reply to P. Castle et al

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Wieke Kremer

Speakers' Bureau: Qiagen

Chris Meijer

Employment: Self-Screen B.V.

Stock and Other Ownership Interests: MDxHealth, Qiagen, Self-Screen B.V.

Honoraria: Qiagen, MSD, GlaxoSmithKline, Ismar Healthcare NV

Consulting or Advisory Role: Qiagen, MSD, GlaxoSmithKline, Ismar Healthcare NV

Speakers' Bureau: Qiagen

Patents, Royalties, Other Intellectual Property: I am a part-time CEO and minority shareholder of Self-Screen B.V., a spin-off company of VUMC that develops, manufactures, and licenses high-risk HPV and methylation marker assays and holds patents on these assays. I do not receive financial compensation of these patents (Inst)

Uncompensated Relationships: Eurogin

No other potential conflicts of interest were reported.